Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1814
Gene Symbol: DRD3
DRD3
0.310 GeneticVariation disease BEFREE The present study aimed to investigate whether selected polymorphisms in the dopamine receptors genes (DRD1, DRD2, DRD3, and DRD4) are associated with PG in Korean population which is consisted of only Korean ancestry. 21853233 2012
Entrez Id: 1814
Gene Symbol: DRD3
DRD3
0.310 Biomarker disease CTD_human Homozygosity at the dopamine DRD3 receptor gene in cocaine dependence. 10523822 1999
Entrez Id: 5360
Gene Symbol: PLTP
PLTP
0.100 GeneticVariation disease GWASCAT Genome-wide association study of pathological gambling. 27315593 2016
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
0.040 PosttranslationalModification disease BEFREE These results point towards a pathophysiologic relevance of altered DRD2-expression due to changes of DNA methylation in pathologic gambling behavior. 26028496 2015
Entrez Id: 1815
Gene Symbol: DRD4
DRD4
0.040 GeneticVariation disease BEFREE The present study aimed to investigate whether selected polymorphisms in the dopamine receptors genes (DRD1, DRD2, DRD3, and DRD4) are associated with PG in Korean population which is consisted of only Korean ancestry. 21853233 2012
Entrez Id: 1815
Gene Symbol: DRD4
DRD4
0.040 GeneticVariation disease BEFREE These are potentially of genetic origin, since research in healthy subjects suggests that vulnerability for pathological gambling may be linked to variation in the dopamine receptor D4 (DRD4) gene. 19914604 2010
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
0.040 Biomarker disease BEFREE Recent studies have suggested the involvement of the dopaminergic system in addictions and impulse control disorders and associations of dopamine receptor genes (DRD1, DRD2, and DRD4) and PG have been reported. 17394052 2007
Entrez Id: 1815
Gene Symbol: DRD4
DRD4
0.040 Biomarker disease BEFREE Recent studies have suggested the involvement of the dopaminergic system in addictions and impulse control disorders and associations of dopamine receptor genes (DRD1, DRD2, and DRD4) and PG have been reported. 17394052 2007
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
0.040 Biomarker disease BEFREE The DRD(2) gene could be a liability genetic factor for psychiatric comorbidity in pathological gambling. 11579014 2001
Entrez Id: 1815
Gene Symbol: DRD4
DRD4
0.040 GeneticVariation disease BEFREE Our results are consistent with the existence of a significant association between genetic variants at a DRD4 gene polymorphism and pathological gambling (chi 2 = 11.82; P = 0.037). 9352568 1997
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
0.040 GeneticVariation disease BEFREE These results suggest that genetic variants at the DRD2 gene play a role in pathological gambling, and support the concept that variants of this gene are a risk factor for impulsive and addictive behaviours. 8807661 1996
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.020 AlteredExpression disease BEFREE Functional DAT down-regulation possibly sustains the transition towards compulsive gambling addiction, characterized both by hyperdopaminergic and hypodopaminergic states in the context of a sensitized dopaminergic system. 30226290 2019
Entrez Id: 6886
Gene Symbol: TAL1
TAL1
0.020 GeneticVariation disease BEFREE (2) Methods: Gambling severity, craving for cocaine, sleep, and other negative affect symptoms were recorded in seven patients with a diagnosis of gambling disorder (South Oaks Gambling Screen (SOGS) >5), in comorbidity with CUD, using the following scales: Gambling-Symptom Assessment Scale (G-SAS), Cocaine Craving Questionnaire (CCQ), Beck Depression Inventory-II (BDI-II), Self-rating Anxiety Scale (SAS), and Symptoms checklist-90 (SCL-90). 31151221 2019
Entrez Id: 3855
Gene Symbol: KRT7
KRT7
0.020 GeneticVariation disease BEFREE (2) Methods: Gambling severity, craving for cocaine, sleep, and other negative affect symptoms were recorded in seven patients with a diagnosis of gambling disorder (South Oaks Gambling Screen (SOGS) >5), in comorbidity with CUD, using the following scales: Gambling-Symptom Assessment Scale (G-SAS), Cocaine Craving Questionnaire (CCQ), Beck Depression Inventory-II (BDI-II), Self-rating Anxiety Scale (SAS), and Symptoms checklist-90 (SCL-90). 31151221 2019
Entrez Id: 51540
Gene Symbol: SCLY
SCLY
0.020 GeneticVariation disease BEFREE (2) Methods: Gambling severity, craving for cocaine, sleep, and other negative affect symptoms were recorded in seven patients with a diagnosis of gambling disorder (South Oaks Gambling Screen (SOGS) >5), in comorbidity with CUD, using the following scales: Gambling-Symptom Assessment Scale (G-SAS), Cocaine Craving Questionnaire (CCQ), Beck Depression Inventory-II (BDI-II), Self-rating Anxiety Scale (SAS), and Symptoms checklist-90 (SCL-90). 31151221 2019
Entrez Id: 51540
Gene Symbol: SCLY
SCLY
0.020 GeneticVariation disease BEFREE All of them were seeking treatment for GD (88.4% male and 11.6% female) and completed the South Oaks Gambling Screen (SOGS), the UPPS-P Impulsive Behavior Scale, the Symptom Checklist (SCL-90-R), the Temperament and Character Inventory-R (TCI-R) as well as other clinical and psychopathological measures. 27810546 2017
Entrez Id: 3855
Gene Symbol: KRT7
KRT7
0.020 GeneticVariation disease BEFREE All of them were seeking treatment for GD (88.4% male and 11.6% female) and completed the South Oaks Gambling Screen (SOGS), the UPPS-P Impulsive Behavior Scale, the Symptom Checklist (SCL-90-R), the Temperament and Character Inventory-R (TCI-R) as well as other clinical and psychopathological measures. 27810546 2017
Entrez Id: 6886
Gene Symbol: TAL1
TAL1
0.020 GeneticVariation disease BEFREE All of them were seeking treatment for GD (88.4% male and 11.6% female) and completed the South Oaks Gambling Screen (SOGS), the UPPS-P Impulsive Behavior Scale, the Symptom Checklist (SCL-90-R), the Temperament and Character Inventory-R (TCI-R) as well as other clinical and psychopathological measures. 27810546 2017
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.020 GeneticVariation disease BEFREE The aim of this study was to identify whether the DRD2/ANKK1 Taq1A-rs1800497 and the DAT1-40 bp VNTR polymorphisms are associated with cognitive flexibility (measured by Wisconsin Card Sorting Test (WCST) and Trail Making Test (TMT)) and inhibition response (measured by Stroop Color and Word Test (SCWT)), in a clinical sample of 69 PG patients. 25237117 2014
Entrez Id: 11074
Gene Symbol: TRIM31
TRIM31
0.010 Biomarker disease BEFREE 94 suspected cases of gambling disorder associated to apomorphine, aripiprazole, cabergoline, levodopa, levodopa and derivatives in association with entacapone/benserazide and carbidopa, pergolide, pramipexole, ropinirole, and rotigotine were reported into the RNF. 30671764 2020
Entrez Id: 11113
Gene Symbol: CIT
CIT
0.010 GeneticVariation disease BEFREE Striatal presynaptic dopaminergic dysfunction in gambling disorder: A <sup>123</sup> I-FP-CIT SPECT study. 30226290 2019
Entrez Id: 1385
Gene Symbol: CREB1
CREB1
0.010 AlteredExpression disease BEFREE This behavioural change appears superficially similar to the iatrogenic gambling disorder (GD) observed in a sub-set of patients with Parkinson's disease (PD), and has been associated with increased activation of the intra-cellular signalling proteins GSK3β and CREB in the striatum. 30019362 2019
Entrez Id: 627
Gene Symbol: BDNF
BDNF
0.010 AlteredExpression disease BEFREE These findings contribute to a better understanding of brain-based electrophysiological changes and BDNF levels in patients with pathological gambling. 29865867 2018
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.010 Biomarker disease BEFREE In patients with active PG, leptin blood levels were not related to craving for gambling, but leptin might be involved in PG via an interaction with the HPA axis. 30041134 2018
Entrez Id: 79947
Gene Symbol: DHDDS
DHDDS
0.010 GeneticVariation disease BEFREE The PG group displayed lower d' values and more conservative response criterion in the CPT. 30564153 2018